24/11/2025
Shalom,
The March 31, 2025 deadline to file Annual Drug Amount Reports has passed. Under Section 510(j)(3) of the Federal Food, Drug, and Cosmetic Act, all registrants with listed drug products or APIs were required to report for each NDC.
Now the clock is ticking again. Companies that do not file by December 31, 2025 will appear on the FDA’s public noncompliance list in early 2026.
Compliance made simple with your trusted FDA partner
For over 20 years, Registrar Corp has guided 30,000+ FDA-regulated companies through complex reporting cycles — accurately and on time. As your U.S. Agent, we:
• Identify the reporting data you must submit for each NDC
• Prepare and file accurate Drug Amount Reports and Establishment Re-Registrations
• Maintain and update your listings throughout the year
• Assist with Self-Identification for generic manufacturers and User Fee remittance
• Resolve detentions and regulatory issues before they escalate
• Provide ongoing compliance guidance so you’re always ready for what’s next
Act now to secure your compliance and protect your company’s reputation before deadlines close in again.
Registrar Corp guides your FDA filings with accuracy and care — protecting your compliance and supporting your company’s integrity.
https://www.registrarcorp.com/